Making sense of schizophrenia.
The syndrome affects 1% of the population, and is probably not a single disease. Clinical observation has identified symptom "dimensions," perhaps related to differing pathophysiologic processes. Meanwhile, pharmacologic investigation implies that schizophrenia cannot be pinned to any single neurotransmitter system. Techniques of brain imaging are now providing glimpses of cognitive dysfunction.